JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHA:600200)
China · Delayed Price · Currency is CNY 1.980
-0.100 (-4.81%)
Jul 17, 2025, 2:45 PM CST
SHA:600200 Revenue
JiangSu WuZhong Pharmaceutical Development had revenue of 317.20M CNY in the quarter ending March 31, 2025, a decrease of -25.44%. This brings the company's revenue in the last twelve months to 1.49B, down -27.43% year-over-year. In the year 2024, JiangSu WuZhong Pharmaceutical Development had annual revenue of 1.60B, down -28.64%.
Revenue (ttm)
1.49B
Revenue Growth
-27.43%
P/S Ratio
0.94
Revenue / Employee
1.36M
Employees
1,096
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.60B | -641.45M | -28.64% |
| Dec 31, 2023 | 2.24B | 213.73M | 10.55% |
| Dec 31, 2022 | 2.03B | 250.78M | 14.12% |
| Dec 31, 2021 | 1.78B | -96.29M | -5.14% |
| Dec 31, 2020 | 1.87B | -238.11M | -11.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |